Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smyth

Showing results (221-230 of 294) with videos related to

Pageof 30
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2011
Clinically relevant fatigue in recurrence-free prostate cancer survivorsD J Storey, D B McLaren, M A Atkinson, et al.
Cancer|March 18, 2008
Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single centerDawn J Storey, Robert Rush, Moira Stewart, et al.
Genome Research|March 17, 1999
Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysisJ E Watson, H Gabra, K J Taylor, et al.
Lancet (London, England)|July 26, 1980
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemiaH G Prentice, J F Smyth, K Ganeshaguru, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycinJ F Smyth, R M Paine, A L Jackman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Expression of the heat shock protein HSP27 in human ovarian cancerS P Langdon, G J Rabiasz, G L Hirst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Neuregulin expression, function, and signaling in human ovarian cancer cellsLynn M R Gilmour, Kenneth G Macleod, Alison McCaig, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Phase I study of TCNU, a novel nitrosoureaJ F Smyth, J S Macpherson, P S Warrington, et al.
Immunology|May 3, 2002
HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activityGrant J Logan, Christine M F Smyth, John W Earl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Cisplatinum and prednimustine, an active regimen for advanced epithelial ovarian cancerJ F Smyth, G J Beattie, M E Stewart, et al.
Pageof 30

Showing results (221-230 of 294) with videos related to

Sort By:
Pageof 30
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2011
Clinically relevant fatigue in recurrence-free prostate cancer survivorsD J Storey, D B McLaren, M A Atkinson, et al.
Cancer|March 18, 2008
Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single centerDawn J Storey, Robert Rush, Moira Stewart, et al.
Genome Research|March 17, 1999
Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysisJ E Watson, H Gabra, K J Taylor, et al.
Lancet (London, England)|July 26, 1980
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemiaH G Prentice, J F Smyth, K Ganeshaguru, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycinJ F Smyth, R M Paine, A L Jackman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Expression of the heat shock protein HSP27 in human ovarian cancerS P Langdon, G J Rabiasz, G L Hirst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Neuregulin expression, function, and signaling in human ovarian cancer cellsLynn M R Gilmour, Kenneth G Macleod, Alison McCaig, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Phase I study of TCNU, a novel nitrosoureaJ F Smyth, J S Macpherson, P S Warrington, et al.
Immunology|May 3, 2002
HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activityGrant J Logan, Christine M F Smyth, John W Earl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Cisplatinum and prednimustine, an active regimen for advanced epithelial ovarian cancerJ F Smyth, G J Beattie, M E Stewart, et al.
Pageof 30